Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 1/20 | 0.38 |
| ▸ | MPO | P05164 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26602774 | 1.00 | TACR2 (0.38) | TACR2MPOTAAR1CHRNB2CHRNB4 | |
| SCHEMBL8260934 | 0.83 | TACR2 (0.39) | TACR2CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL3956306 | 0.80 | TACR2 (0.39) | TACR2CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL29572531 | 0.80 | TACR2 (0.39) | TACR2CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL5493492 | 0.80 | TACR2 (0.39) | TACR2CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL3956308 | 0.80 | TACR2 (0.39) | TACR2CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL26645821 | 0.80 | HTR1D (0.37) | — | |
| SCHEMBL7436995 | 0.80 | HTR6 (0.46) | HTR2AHTR2C | |
| SCHEMBL26645819 | 0.80 | HTR1D (0.37) | — | |
| SCHEMBL26639689 | 0.80 | HTR6 (0.46) | HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119522212-A | Indoline derivatives as serotonergic agents for the treatment of related disorders | 思维模式制药公司 | 2025-02-25 | — | — | CN | disclosed |